Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins

  • Alonso-Lerma, Borja
  • Güell Cargol, Marc, 1982-
  • Perez-Jimenez, Raul
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas9 is an effector protein that targets invading DNA and plays a major role in the prokaryotic adaptive immune system. Although Streptococcus pyogenes CRISPR-Cas9 has been widely studied and repurposed for applications including genome editing, its origin and evolution are poorly understood. Here, we investigate the evolution of Cas9 from resurrected ancient nucleases (anCas) in extinct firmicutes species that last lived 2.6 billion years before the present. We demonstrate that these ancient forms were much more flexible in their guide RNA and protospacer-adjacent motif requirements compared with modern-day Cas9 enzymes. Furthermore, anCas portrays a gradual palaeoenzymatic adaptation from nickase to double-strand break activity, exhibits high levels of activity with both single-stranded DNA and single-stranded RNA targets and is capable of editing activity in human cells. Prediction and characterization of anCas with a resurrected protein approach uncovers an evolutionary trajectory leading to functionally flexible ancient enzymes., This work has been supported by grant nos. PID2019-109087RB-I00 (to R.P.-J.) and RTI2018-101223-B-I00 and PID2021-127644OB-I00 (to L.M.) from the Spanish Ministry of Science and Innovation. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 964764 (to R.P.-J.). The content presented in this document represents the views of the authors, and the European Commission has no liability in respect to the content. We acknowledge financial support from the Spanish Foundation for the Promotion of Research of Amyotrophic Lateral Sclerosis. A.F. acknowledges Spanish Center for Biomedical Network Research on Rare Diseases (CIBERE) intramural funds (no. ER19P5AC756/2021). F.J.M.M. acknowledges research support by Conselleria d’Educació, Investigació, Cultura i Esport from Generalitat Valenciana, research project nos. PROMETEO/2017/129 and PROMETEO/2021/057. M.M. acknowledges funding from CIBERER (grant no. ER19P5AC728/2021). The work has received funding from the Regional Government of Madrid (grant no. B2017/BMD3721 to M.A.M.-P.) and from Instituto de Salud Carlos III, cofounded with the European Regional Development Fund ‘A way to make Europe’ within the National Plans for Scientific and Technical Research and Innovation 2017–2020 and 2021–2024 (nos. PI17/1659, PI20/0429 and IMP/00009; to M.A.M.-P. B.P.K. was supported by an MGH ECOR Howard M. Goodman Award and NIH P01 HL142494. We thank H. Stutzman for assistance with cloning plasmids, and Z. Herbert and M. Berkeley from the Molecular Biology Core Facilities at the Dana-Farber Cancer Institute for assistance with NextSeq sequencing.
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

High-throughput virtual search of small molecules for controlling the mechanical stability of human CD4

  • Reifs, Antonio
  • Fernandez-Calvo, Alba
  • Alonso-Lerma, Borja
  • Schönfelder, Jörg
  • Franco, David
  • Ortega-Muñoz, Mariano|||0000-0002-2395-9391
  • Casares Atienza, Salvador|||0000-0001-7257-2196
  • Jiménez López, Concepción|||0000-0002-5645-2079
  • Saa, Laura
  • Cortajarena, Aitziber L.
  • De Sancho, David
  • San Sebastián, Eider
  • Pérez Jiménez, Raúl
Protein mechanical stability determines the function of a myriad of proteins, especially proteins from the extracellular matrix. Failure to maintain protein mechanical stability may result in diseases and disorders such as cancer, cardiomyopathies, or muscular dystrophy. Thus, developing mutation-free approaches to enhance and control the mechanical stability of proteins using pharmacology-based methods may have important implications in drug development and discovery. Here, we present the first approach that employs computational high-throughput virtual screening and molecular docking to search for small molecules in chemical libraries that function as mechano-regulators of the stability of human cluster of differentiation 4, receptor of HIV-1. Using single-molecule force spectroscopy, we prove that these small molecules can increase the mechanical stability of CD4D1D2 domains over 4-fold in addition to modifying the mechanical unfolding pathways. Our experiments demonstrate that chemical libraries are a source of mechanoactive molecules and that drug discovery approaches provide the foundation of a new type of molecular function, that is, mechano-regulation, paving the way toward mechanopharmacology., Grants PID2019-109087RB-I00 and PID2022-141347OBI00, from the Spanish Ministry of Science and Innovation and Spanish Research Agency funded by MCIN/AEI 10.13039/501100011033 and the European Regional Development Fund (FEDER), European Union’s Horizon 2020 research and innovation program under grant agreement No 964764, Eusko Jaurlaritza (Basque Government) through the projects IT1755-22, IT1584-22 and KK-2021/00009, and PID2021- 127907NB-I00 from MCIN/AEI, PID2022-137977OB-I00) from the Spanish Ministry of Science and Innovation and Spanish Research Agency funded by MCIN/AEI/10.13039/501100011033, Ochoa Excellence Program grant CEX2021-001136-S funded by MCIN/AEI 10.13039/501100011033, Maria de Maeztu Units of Excellence Program from Q5, grant no. MDM-2017-0720 funded by MCIN/AEI
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

High-throughput virtual search of small molecules for controlling the mechanical stability of human CD4

  • Reifs, Antonio
  • Fernández Calvo, Alba
  • Alonso Lerma, Borja
  • Schönfelder, Jörg
  • Franco Veiga, David
  • Ortega Muñoz, Mariano
  • Casares, Salvador
  • Jiménez López, Concepción
  • Saa, Laura
  • López Cortajarena, Aitziber
  • De Sancho Sánchez, David
  • San Sebastián Larzabal, Eider
  • Pérez Jiménez, Raúl
Protein mechanical stability determines the function of a myriad of proteins, especially proteins from the extracellular matrix. Failure to maintain protein mechanical stability may result in diseases and disorders such as cancer, cardiomyopathies, or muscular dystrophy. Thus, developing mutation-free approaches to enhance and control the mechanical stability of proteins using pharmacology-based methods may have important implications in drug development and discovery. Here, we present the first approach that employs computational high-throughput virtual screening and molecular docking to search for small molecules in chemical libraries that function as mechano-regulators of the stability of human cluster of differentiation 4, receptor of HIV-1. Using single-molecule force spectroscopy, we prove that these small molecules can increase the mechanical stability of CD4D1D2 domains over 4-fold in addition to modifying the mechanical unfolding pathways. Our experiments demonstrate that chemical libraries are a source of mechanoactive molecules and that drug discovery approaches provide the foundation of a new type of molecular function, that is, mechano-regulation, paving the way toward mechanopharmacology., This work has been supported by grants PID2019-109087RB-I00 and PID2022-141347OB-I00 (to R. P.-J.) from the Spanish Ministry of Science and Innovation and Spanish Research Agency funded by MCIN/AEI 10.13039/501100011033 and the European Regional Development Fund (FEDER). This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 964764 (to R. P.-J). Financial support to D. D. S. comes from Eusko Jaurlaritza (Basque Government) through the projects IT1755-22, IT1584-22 and KK-2021/00009, and PID2021-127907NB-I00 from MCIN/AEI. A. L. C. acknowledges the financial support (grant PID2022-137977OB-I00) from the Spanish Ministry of Science and Innovation and Spanish Research Agency funded by MCIN/AEI/10.13039/501100011033. We acknowledge the Severo Ochoa Excellence Program grant CEX2021-001136-S funded by MCIN/AEI 10.13039/501100011033. This work was performed under the Maria de Maeztu Units of Excellence Program from Q5, grant no. MDM-2017-0720 funded by MCIN/AEI.
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

Enzymatic upgrading of nanochitin using an ancient lytic polysaccharide monooxygenase

  • Barandiaran, Leire
  • Alonso Lerma, Borja
  • Reifs, Antonio
  • Larraza Arocena, Izaskun
  • Olmos Juste, Raquel
  • Fernández Calvo, Alba
  • Jabalera, Ylenia
  • Eceiza Mendiguren, María Aranzazu
  • Pérez Jiménez, Raúl
Numerous enzymes have the potential to upgrade biomass, converting it into high-tech materials for new applications. However, the features of natural enzymes often limit their use beyond chemical conversion of the substrate. The development of strategies for the enzymatic conversion of biomass into high-value materials may broaden the range of applications of enzymes and enzyme design techniques. A relevant case is lytic polysaccharide monooxygenase (LPMO), a class of enzymes that catalyzes the oxidative cleavage of glycosidic bonds. Here, we show that an ancestral LPMO can generate chitin nanocrystals. Physicochemical characterization of the chitin nanocrystals demonstrates modifications that make it superior compared to chitin obtained by chemical treatments. We show that the nanocrystals are suitable for controlled 2D and 3D cell cultures, as well as for engineering a biomatrix that combines with graphene oxide, forming a hybrid conductive bioink., This work has been supported by grants PID2019-109087RB-I00 to R.P.-J. from Spanish Ministry of Science and Innovation. This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 964764 to R.P.-J. ‘Materials + Technologies’ Research Group also acknowledges UPV/EHU and the Basque Government in the frame of “Research Group” (GIU 18/216) and “Grupos Consolidados” (IT776-13), respectively. We also thank Gipuzkoako Foru Aldundia for financial Support. HEK293T cells were a kind gift from Dr. Maria Muñoz Caffarel (Biodonostia, San Sebastian, Spain).
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

Self-assembly and crystallization of double crystalline aliphatic thermoplastic biopolyurethane and its nucleation with cellulose nanocrystals

  • Fernández d'Arlas Bidegain, Borja
  • Arteaga, Ana Gabriella
  • Saralegi Otamendi, Ainara
  • Corcuera Maeso, María Ángeles
  • Eceiza Mendiguren, María Aranzazu
  • Müller Sánchez, Alejandro Jesús
[EN] An aliphatic segmented thermoplastic biopolyurethane (STPU), based on aliphatic hexamethylene diisocyanate (HDI) and 1,3 propanediol (1,3PD) as urethane rich phase and a poly(sebacate) as a macrodiol phase, with ~50 wt% of renewable carbon content, was synthetized and mixed with cellulose nanocrystals (CNC) to develop new bionanocomposites. The phase behaviour of the STPU and derived bionanocomposites was analysed with a variety of techniques which include differential scanning calorimetry (DSC), isothermal crystallization, X-ray scattering and atomic force microscopy (AFM). The Isothermal crystallization of the STPU matrix allowed fitting to the Lauritzen-Hofmann model and calculation of the overall crystallization constant, Kg. Further dynamic thermal analysis by X-ray scattering and DSC allowed the determination of the impact of CNC on the morphology and nucleation of the urethane rich phase. Self-nucleation experiments with the STPU matrix allowed quantification of the nucleation effect of the CNC., A.Eceiza and A. Saralegi acknowledge funding from the University of the Basque Country (UPV/EHU) (GIU18/216 Research Group). Moreover, authors are grateful to the Macrobehavior-Mesostructure-Nanotechnology SGIker unit of the UPV/EHU. This work has received funding from the Basque Government through grant IT1309-19. BFD wants to acknowledge Prof. Raúl Pérez Jiménez from NanoGUNE and ‘BioUPGRADE’ European Commission Project.
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

The strongest protein binder is surprisingly labile

  • Fernández Calvo, Alba
  • Reifs, Antonio
  • Saa, Laura
  • López Cortajarena, Aitziber
  • De Sancho Sánchez, David
  • Pérez Jiménez, Raúl
Bacterial adhesins are cell-surface proteins that anchor to the cell wall of the host. The first stage of infection involves the specific attachment to fibrinogen (Fg), a protein found in human blood. This attachment allows bacteria to colonize tissues causing diseases such as endocarditis. The study of this family of proteins is hence essential to develop new strategies to fight bacterial infections. In the case of the Gram-positive bacterium Staphylococcus aureus, there exists a class of adhesins known as microbial surface components recognizing adhesive matrix molecules (MSCRAMMs). Here, we focus on one of them, the clumping factor A (ClfA), which has been found to bind Fg through the dock-lock-latch mechanism. Interestingly, it has recently been discovered that MSCRAMM proteins employ a catch-bond to withstand forces exceeding 2 nN, making this type of interaction as mechanically strong as a covalent bond. However, it is not known whether this strength is an evolved feature characteristic of the bacterial protein or is typical only of the interaction with its partner. Here, we combine single-molecule force spectroscopy, biophysical binding assays, and molecular simulations to study the intrinsic mechanical strength of ClfA. We find that despite the extremely high forces required to break its interactions with Fg, ClfA is not by itself particularly strong. Integrating the results from both theory and experiments we dissect contributions to the mechanical stability of this protein., This work has been supported by grants PID2019-109087RB-I00 and PID2022-141347OB-I00 to R.P.-J. from Spanish Ministry of Science and Innovation and Spanish Research Agency funded by MCIN/AEI 10.13039/501100011033 and FEDER. This work has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 964764 to R.P.-J. Financial support to D. D comes from Eusko Jaurlaritza (Basque Government) IT1584-22, and from the Spanish Ministry of Science and Universities through the Office of Science Research (MINECO/FEDER) through grant PID2021-127907NB-I00 from MCIN/AEI. A.L.C. acknowledges financial support from grants: PID2022-137977OB-I00 funded by MCIN/AEI/10.13039/501100011033. We acknowledge the Severo Ocho Excellence Program grant CEX2021-001136-S funded by MCIN/AEI 10.13039/501100011033. This work was performed under the Maria de Maeztu Units of Excellence Program from Q5, grant no. MDM-2017-0720 funded by MCIN/AEI.
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

Compliant mechanical response of the ultrafast folding protein EnHD under force

  • Reifs, Antonio
  • Ruiz Ortiz, Irene
  • Ochandorena Saa, Amaia
  • Schönfelder, Jörg
  • De Sancho Sánchez, David
  • Muñoz, Víctor
  • Pérez Jiménez, Raúl
Ultrafast folding proteins have become an important paradigm in the study of protein folding dynamics. Due to their low energetic barriers and fast kinetics, they are amenable for study by both experiment and simulation. However, single molecule force spectroscopy experiments on these systems are challenging as these proteins do not provide the mechanical fingerprints characteristic of more mechanically stable proteins, which makes it difficult to extract information about the folding dynamics of the molecule. Here, we investigate the unfolding of the ultrafast protein Engrailed Homeodomain (EnHD) by single-molecule atomic force microscopy experiments. Constant speed experiments on EnHD result in featureless transitions typical of compliant proteins. However, in the force-ramp mode we recover sigmoidal curves that we interpret as a very compliant protein that folds and unfolds many times over a marginal barrier. This is supported by a simple theoretical model and coarse-grained molecular simulations. Our results show the ability of force to modulate the unfolding dynamics of ultrafast folding proteins., This work has been supported by grants PID2019-109087RB-I00 to R.P.-J. and PGC2018-099321-B-I00 and RYC-2016-19590 to D.D. from the Spanish Ministry of Science and Innovation. This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 964764 to R.P.-J. D.D. receives support from Eusko Jaurlaritza (Basque Government) through the project IT1254-19. A.R. is the recipient of a doctorate fellowship from the Spanish Ministry of Science and Innovation. I.R.-O. acknowledges financial support from Donostia International Physics Center (DIPC).
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins

  • Alonso-Lerma, Borja
  • Jabalera, Ylenia
  • Samperio, Sara
  • Morin, Matias
  • Fernandez, Almudena
  • Hille, Logan T.
  • Silverstein, Rachel A.
  • Quesada-Ganuza, Ane
  • Reifs, Antonio
  • Fernández-Peñalver, Sergio
  • Benitez, Yolanda
  • Soletto, Lucia
  • Gavira, Jose A.
  • Diaz, Adrian
  • Vranken, Wim
  • Sanchez-Mejias, Avencia
  • Güell, Marc
  • Mojica, Francisco J.M.
  • Kleinstiver, Benjamin P.
  • Moreno-Pelayo, Miguel A.
  • Montoliu, Lluis
  • Perez-Jimenez, Raul
  • Mojica, Francisco J.M.|||/items/f14a8472-85f4-48a8-bb8d-3ee259963240
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas9 is an effector protein that targets invading DNA and plays a major role in the prokaryotic adaptive immune system. Although Streptococcus pyogenes CRISPR–Cas9 has been widely studied and repurposed for applications including genome editing, its origin and evolution are poorly understood. Here, we investigate the evolution of Cas9 from resurrected ancient nucleases (anCas) in extinct firmicutes species that last lived 2.6 billion years before the present. We demonstrate that these ancient forms were much more flexible in their guide RNA and protospacer-adjacent motif requirements compared with modern-day Cas9 enzymes. Furthermore, anCas portrays a gradual palaeoenzymatic adaptation from nickase to double-strand break activity, exhibits high levels of activity with both single-stranded DNA and single-stranded RNA targets and is capable of editing activity in human cells. Prediction and characterization of anCas with a resurrected protein approach uncovers an evolutionary trajectory leading to functionally flexible ancient enzymes.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins

  • Alonso-Lerma, Borja
  • Jabalera, Ylenia
  • Samperio, Sara
  • Morin, Matías
  • Fernández, Almudena
  • Hille, Logan T.
  • Silverstein, Rachel A.
  • Quesada-Ganuza, Ane
  • Reifs, Antonio
  • Fernández-Peñalver, Sergio
  • Benitez, Yolanda
  • Soletto, Lucia
  • Gavira, Jose A.
  • Diaz, Adrian
  • Vranken, Wim
  • Sánchez-Mejías, Avencia
  • Güell, Marc
  • Mójica, Francisco J. M.
  • Kleinstiver, Benjamin P.
  • Moreno-Pelayo, Miguel Ángel
  • Montoliu, Lluís
  • Pérez-Jiménez, Raúl
Extended data is available for this paper at https://doi.org/10.1038/s41564-022-01265-y. Supplementary information The online version contains supplementary material available at https://doi.org/10.1038/s41564-022-01265-y., Clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas9 is an effector protein that targets invading DNA and plays a major role in the prokaryotic adaptive immune system. Although Streptococcus pyogenes CRISPR-Cas9 has been widely studied and repurposed for applications including genome editing, its origin and evolution are poorly understood. Here, we investigate the evolution of Cas9 from resurrected ancient nucleases (anCas) in extinct firmicutes species that last lived 2.6 billion years before the present. We demonstrate that these ancient forms were much more flexible in their guide RNA and protospacer-adjacent motif requirements compared with modern-day Cas9 enzymes. Furthermore, anCas portrays a gradual palaeoenzymatic adaptation from nickase to double-strand break activity, exhibits high levels of activity with both single-stranded DNA and single-stranded RNA targets and is capable of editing activity in human cells. Prediction and characterization of anCas with a resurrected protein approach uncovers an evolutionary trajectory leading to functionally flexible ancient enzymes., This work has been supported by grant nos. PID2019-109087RB-I00 (to R.P.-J.) and RTI2018-101223-B-I00 and PID2021-127644OB-I00 (to L.M.) from the Spanish Ministry of Science and Innovation. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 964764 (to R.P.-J.). The content presented in this document represents the views of the authors, and the European Commission has no liability in respect to the content. We acknowledge financial support from the Spanish Foundation for the Promotion of Research of Amyotrophic Lateral Sclerosis. A.F. acknowledges Spanish Center for Biomedical Network Research on Rare Diseases (CIBERE) intramural funds (no. ER19P5AC756/2021). F.J.M.M. acknowledges research support by Conselleria d’Educació, Investigació, Cultura i Esport from Generalitat Valenciana, research project nos. PROMETEO/2017/129 and PROMETEO/2021/057. M.M. acknowledges funding from CIBERER (grant no. ER19P5AC728/2021). The work has received funding from the Regional Government of Madrid (grant no. B2017/BMD3721 to M.A.M.-P.) and from Instituto de Salud Carlos III, cofounded with the European Regional Development Fund ‘A way to make Europe’ within the National Plans for Scientific and Technical Research and Innovation 2017–2020 and 2021–2024 (nos. PI17/1659, PI20/0429 and IMP/00009; to M.A.M.-P. B.P.K. was supported by an MGH ECOR Howard M. Goodman Award and NIH P01 HL142494., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A resurrected ancestor of Cas12a expands target access and substrate recognition for nucleic acid editing and detection

  • Jabalera, Ylenia
  • Tascón, Igor
  • Samperio, Sara
  • López-Alonso, Jorge P.
  • Gonzalez-Lopez, Monika
  • Aransay, Ana M.
  • Abascal-Palacios, Guillermo
  • Beisel, Chase L.
  • Ubarretxena-Belandia, Iban
  • Pérez-Jiménez, Raúl
The properties of Cas12a nucleases constrict the range of accessible targets and their applications. In this study, we applied ancestral sequence reconstruction (ASR) to a set of Cas12a orthologs from hydrobacteria to reconstruct a common ancestor, ReChb, characterized by near-PAMless targeting and the recognition of diverse nucleic acid activators and collateral substrates. ReChb shares 53% sequence identity with the closest Cas12a ortholog but no longer requires a T-rich PAM and can achieve genome editing in human cells at sites inaccessible to the natural FnCas12a or the engineered and PAM-flexible enAsCas12a. Furthermore, ReChb can be triggered not only by double-stranded DNA but also by single-stranded RNA and DNA targets, leading to non-specific collateral cleavage of all three nucleic acid substrates with similar efficiencies. Finally, tertiary and quaternary structures of ReChb obtained by cryogenic electron microscopy reveal the molecular details underlying its expanded biophysical activities. Overall, ReChb expands the application space of Cas12a nucleases and underscores the potential of ASR for enhancing CRISPR technologies., This work has been supported by grants PID2019-109087RB-I00 and PID2022-141347OB-I00 to R.P.-J.; PID2019-104423GB-I00 and PID2022-143177NB-I00 to I.U.-B.; and PID2021-126263OA-I00 to G.A.-P., funded by the Spanish Ministry of Science and Innovation (MICIU/AEI/10.13039/501100011033). This project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under grant agreement number 964764 to R.P.-J. and from a European Research Council Consolidator Award (grant agreement number 865973) to C.L.B. The content presented in this paper represents the views of the authors, and the European Commission has no liability with respect to the content. Y.J. acknowledges financial support from Juan de la Cierva program grant FJC2021-047689-I, funded by the Spanish Ministry of Science and Innovation (MICIU/AEI/10.13039/501100011033) and by European Union NextGenerationEU/PRTR. R.P.-J. and Y.J. acknowledge financial support from the Spanish Foundation for the Promotion of Research of Amyotrophic Lateral Sclerosis (FUNDELA). J.P.L.-A. acknowledges financial support from a PTA contract granted by the MCIN/AEI. CIC bioGUNE support was provided from the Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Elkartek Research Programs 2020–2023), the Innovation Technology Department of the Bizkaia County and MINECO for the Severo Ochoa Center of Excellence Accreditation (CEX2021-001136-S). CIBERehd is funded by the Instituto de Salud Carlos III. High-resolution cryo-EM data collection was performed at the Basque Resource for Electron Microscopy, supported primarily by the Department of Education and the Innovation Fund of the Basque Government, the Fundación Biofísica Bizkaia and the Spanish Ministry of Science and Innovation, through the Plan de Recuperación, Transformación y Resiliencia (PRTR), funded by the NextGenerationEU (PRTR-C17.I1) program., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins

  • Alonso-Lerma, Borja
  • Güell Cargol, Marc, 1982-
  • Perez-Jimenez, Raul
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas9 is an effector protein that targets invading DNA and plays a major role in the prokaryotic adaptive immune system. Although Streptococcus pyogenes CRISPR-Cas9 has been widely studied and repurposed for applications including genome editing, its origin and evolution are poorly understood. Here, we investigate the evolution of Cas9 from resurrected ancient nucleases (anCas) in extinct firmicutes species that last lived 2.6 billion years before the present. We demonstrate that these ancient forms were much more flexible in their guide RNA and protospacer-adjacent motif requirements compared with modern-day Cas9 enzymes. Furthermore, anCas portrays a gradual palaeoenzymatic adaptation from nickase to double-strand break activity, exhibits high levels of activity with both single-stranded DNA and single-stranded RNA targets and is capable of editing activity in human cells. Prediction and characterization of anCas with a resurrected protein approach uncovers an evolutionary trajectory leading to functionally flexible ancient enzymes., This work has been supported by grant nos. PID2019-109087RB-I00 (to R.P.-J.) and RTI2018-101223-B-I00 and PID2021-127644OB-I00 (to L.M.) from the Spanish Ministry of Science and Innovation. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 964764 (to R.P.-J.). The content presented in this document represents the views of the authors, and the European Commission has no liability in respect to the content. We acknowledge financial support from the Spanish Foundation for the Promotion of Research of Amyotrophic Lateral Sclerosis. A.F. acknowledges Spanish Center for Biomedical Network Research on Rare Diseases (CIBERE) intramural funds (no. ER19P5AC756/2021). F.J.M.M. acknowledges research support by Conselleria d’Educació, Investigació, Cultura i Esport from Generalitat Valenciana, research project nos. PROMETEO/2017/129 and PROMETEO/2021/057. M.M. acknowledges funding from CIBERER (grant no. ER19P5AC728/2021). The work has received funding from the Regional Government of Madrid (grant no. B2017/BMD3721 to M.A.M.-P.) and from Instituto de Salud Carlos III, cofounded with the European Regional Development Fund ‘A way to make Europe’ within the National Plans for Scientific and Technical Research and Innovation 2017–2020 and 2021–2024 (nos. PI17/1659, PI20/0429 and IMP/00009; to M.A.M.-P. B.P.K. was supported by an MGH ECOR Howard M. Goodman Award and NIH P01 HL142494. We thank H. Stutzman for assistance with cloning plasmids, and Z. Herbert and M. Berkeley from the Molecular Biology Core Facilities at the Dana-Farber Cancer Institute for assistance with NextSeq sequencing.